Quantcast

Latest Parkinson's Stories

2014-09-09 12:29:41

Free Educational Seminars, Designed with Community Input, Provide Practical Tips for People with Parkinson's and Continuing Education for Health Professionals NEW YORK, Sept. 9, 2014 /PRNewswire-USNewswire/ -- The Parkinson's Disease Foundation® (PDF®) is pleased to announce its sixth series of PD ExpertBriefings, free interactive seminars presented by leaders in Parkinson's disease research and care. Designed for people living with Parkinson's disease and health care...

2014-09-09 12:28:04

- Only 28% of Parkinson's patients are currently receiving care from a Parkinson's specialist NEW YORK, Sept. 9, 2014 /PRNewswire-USNewswire/ -- A recent survey of more than 1,500 Parkinson's disease (PD) patients, caregivers and physicians reveals that information and specialized care can help patients become more engaged in their own treatment and in the Parkinson's community. http://photos.prnewswire.com/prnvar/20140909/144393 "When patients get to the right doctor, it...

2014-08-12 08:31:15

NEW YORK, Aug. 12, 2014 /PRNewswire-USNewswire/ -- Research projects from five groups active in Parkinson's research comprise the 2014 first half (1H 2014) of The Michael J. Fox Foundation for Parkinson's Research (MJFF) Partnering Program. Among the most promising in the MJFF portfolio, Partnering Program projects are presented directly to industry groups who may wish to invest in further development. By connecting industry leaders with those studies ripe for investment, the...

2014-08-05 16:27:31

GRAND RAPIDS, Mich., Aug. 5, 2014 /PRNewswire/ -- Van Andel Research Institute (VARI) is scheduled to host Rallying to the Challenge, a meeting which highlights the many ways people with Parkinson's disease can impact the clinical trial process and accelerate access to new Parkinson's disease treatments. http://photos.prnewswire.com/prnvar/20140417/76339 The meeting will take place during the third annual Grand Challenges in Parkinson's Disease symposium, one of the most...

2014-08-05 12:32:03

NEW YORK, Aug. 5, 2014 /PRNewswire-USNewswire/ -- Researchers need to know the genetic profiles of their study participants to understand more about how certain mutations manifest disease. But do the participants have to know? A group of 35 Parkinson's disease (PD) researchers published today in Genetics of Medicine the different answers to that question among sites investigating mutations in the LRRK2 gene, the greatest known genetic contributor to PD. Investigators from The Michael...

2014-07-31 12:29:21

AFFiRiS AG presents Phase I data on a first-of-its-kind treatment with support from The Michael J. Fox Foundation NEW YORK and VIENNA, July 31, 2014 /PRNewswire/ -- AFFiRiS AG announced today at a press conference in New York results of AFF008, a Phase I clinical trial of PD01A, a vaccine against Parkinson's disease. PD01A is the first therapy against the protein alpha-synuclein, a promising Parkinson's drug target, to enter clinical testing. The Michael J. Fox...

2014-07-29 08:33:46

VIENNA, July 29, 2014 /PRNewswire/ -- What: AFFiRiS AG, Vienna, Austria will present data from a Phase I clinical trial of PD01A, a vaccine approach that aims to slow or stop Parkinson's disease progression. The Michael J. Fox Foundation supported the study with a $ 1.5 million grant and will discuss the impact of the results for patients and the Parkinson's research community. When: Thursday, July 31, 2014 11.00 am EST (Eastern Standard Time) 03.00 pm UTC...

2014-07-28 08:30:24

ATLANTA, July 28, 2014 /PRNewswire-USNewswire/ -- RaceTrac announced that its cumulative giving to The Michael J. Fox Foundation for Parkinson's Research has exceeded $1 million. This milestone is due in large part to the continued efforts of their team members who have executed various initiatives over the years encouraging the community to participate in and support a worthy cause. "In four short years, RaceTrac has shown incredible generosity and commitment not only financially...

2014-07-24 12:28:19

More Than 30 Scientific Projects Chosen for Potential to Improve the Lives and Futures of People Touched by Parkinson's NEW YORK, July 24, 2014 /PRNewswire-USNewswire/ -- The Parkinson's Disease Foundation® (PDF®) is pleased to announce $1.3 million in funding for more than 30 investigator-initiated research projects to help solve, treat and end Parkinson's disease. Chosen through a competitive application process, the grants reflect PDF's continued commitment to improving the...

2014-07-24 08:35:23

VIENNA, July 24, 2014 /PRNewswire/ -- What: AFFiRiS AG, Vienna, Austria will present data from a Phase I clinical trial of PD01A, a vaccine approach that aims to slow or stop Parkinson's disease progression. The Michael J. Fox Foundation supported the study with a $ 1.5 million grant and will discuss the impact of the results for patients and the Parkinson's research community. When: Thursday, July 31, 2014 11.00 am EST (Eastern Standard Time) 03.00 pm UTC...


Word of the Day
omadhaun
  • A fool; a simpleton: a term of abuse common in Ireland and to a less extent in the Gaelic-speaking parts of Scotland.
This word is partly Irish in origin.